Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 19 citing articles:

Elevated BEAN1 expression correlates with poor prognosis, immune evasion, and chemotherapy resistance in rectal adenocarcinoma
Tiannake Shapaer, Yi Chen, Yipeng Pan, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 15
Induction immunochemotherapy followed by definitive chemoradiotherapy for unresectable locally advanced non‐small cell lung cancer: a multi‐institutional retrospective cohort study
Leilei Wu, Bo Cheng, Xiaojiang Sun, et al.
MedComm (2024) Vol. 5, Iss. 3
Open Access | Times Cited: 6
Chemotherapy-free radiotherapy combined with immune checkpoint inhibitors: a new regimen for locally advanced non-small cell lung cancer?
Lin Ma, Liufu Deng, Jianfeng Peng, et al.
Cancer Biology and Medicine (2024) Vol. 20, Iss. 12, pp. 1035-1046
Open Access | Times Cited: 4
Integration of Circulating Tumor DNA and Metabolic Parameters on 18F‐Fludeoxyglucose Positron Emission Tomography for Outcome Prediction in Unresectable Locally Advanced Non‐Small Cell Lung Cancer
Leilei Wu, Zhenshan Zhang, Chenxue Jiang, et al.
Advanced Science (2025)
Open Access
Innovative dual-gene delivery platform using miR-124 and PD-1 via umbilical cord mesenchymal stem cells and exosome for glioblastoma therapy
Po‐Fu Yueh, I‐Tsang Chiang, Yueh‐Shan Weng, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Current Research in Drug-Free Cancer Therapies
Akshaya Andavar, Varsha Rajesh Bhagavathi, J Cousin, et al.
Bioengineering (2025) Vol. 12, Iss. 4, pp. 341-341
Open Access
Neoadjuvant immunotherapy for NSCLC: superior combination strategies, optimal treatment cycles, and predictive indicators from a Bayesian meta-analysis
Y. Liu, Jianlin Long, Huan Deng, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Fraction Dose Escalation of Hypofractionated Radiotherapy with Concurrent Chemotherapy and Subsequent Consolidation Immunotherapy in Locally Advanced Non–Small Cell Lung Cancer: A Phase I Study
Rui Zhou, FangJie Liu, HongMei Zhang, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 13, pp. 2719-2728
Closed Access | Times Cited: 3
The role of chemoradiotherapy and immunotherapy in stage III NSCLC
Zsuzsanna Orosz, Árṕad Kov́acs
Pathology & Oncology Research (2024) Vol. 30
Open Access | Times Cited: 2
Efficacy and safety of concurrent immune checkpoint inhibitors combined with radiotherapy or chemoradiotherapy for advanced non-small cell lung cancer: A systematic review and single-arm meta-analysis
Ran Cui, Jianrong Li, Xinlin Yu, et al.
PLoS ONE (2024) Vol. 19, Iss. 6, pp. e0304941-e0304941
Open Access | Times Cited: 2
Interplay of Sphingolipid Metabolism in Predicting Prognosis of GBM Patients: Towards Precision Immunotherapy
Qi Wang, Chuanhua Zheng, Hanjin Hou, et al.
Journal of Cancer (2023) Vol. 15, Iss. 1, pp. 275-292
Open Access | Times Cited: 4
HOXC9 characterizes a suppressive tumor immune microenvironment and integration with multiple immune biomarkers predicts response to PD-1 blockade plus chemotherapy in lung adenocarcinoma
Liang Liu, Zhenshan Zhang, Chenxue Jiang, et al.
Aging (2024)
Open Access | Times Cited: 1
kpoint Inhibitors Combined with Radiotherapy or Chemoradiotherapy for Advanced Non-Small Cell Lung Cancer: A Systematic Review and Single-Arm Meta-Analysis v2
Ran Cui
(2024)
Open Access | Times Cited: 1
Causal Associations of Immune Cell Phenotypes with Migraine: A Mendelian Randomization Study
Weifang Chai, Weihao Chai, Fei Guo
Molecular Pain (2024) Vol. 20
Open Access | Times Cited: 1
Immunoradiotherapy for NSCLC: mechanisms, clinical outcomes, and future directions
He Weishan, Zheng Dong-lin, Deng Guangmei, et al.
Clinical & Translational Oncology (2023) Vol. 26, Iss. 5, pp. 1063-1076
Open Access | Times Cited: 2
Exosome-Derived miRNAs in Liquid Biopsy for Lung Cancer
Israel Martínez-Espinosa, José A. Serrato, Carlos Cabello-Gutiérrez, et al.
Life (2024) Vol. 14, Iss. 12, pp. 1608-1608
Open Access
Survival benefit of local consolidative therapy for patients with single-organ metastatic pancreatic cancer: a propensity score-matched cross-sectional study based on 17 registries
Xiaolong Hu, Dan Hu, Bowen Fu, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 1
The Efficacy and Safety of Immunotherapy Followed by Thoracic Radiation in Advanced Non-small Cell Lung Cancer: A Retrospective Analysis
Hong Lian, Ming Zhao, Ji Mei Meng, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
The metabolic repression effect of carbon-ion radiotherapy in synchronous hormone-sensitive oligometastatic prostate cancer
Zhenshan Zhang, Yulei Pei, Wei Hu, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access
Page 1

Scroll to top